Conditions: COPD (Chronic Obstructive Pulmonary Disease); ALS (Amyotrophic Lateral Sclerosis); MS (Multiple Sclerosis); Major Depressive Disorder (MDD); Atypical Parkinson Disease
Interventions: Drug: Psilocybin therapy
Sponsors: University Medical Center Groningen; HumanKindLabs; University of Copenhagen; CTC Clinical Trial Consultants AB; OPEN Foundation; IESE Business School; Uppsala University; The Champalimaud Centre, Lisbon, Portugal; Stockholm University; University of Groningen, The Netherlands; National Institute of Mental Health (NIMH), Prague, Czech Republic; European Association for Palliative Care (EAPC); Madopa; Bispebjerg Hospital, Copenhagen, Denmark; European Association of Neurological Associations (EFNA); 29k International AB; Lung Alliance Netherlands; European Psychiatric Association; Norrsken Mind
Not yet recruiting

Lue lisää...